Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B

J Adler-Moore, RE Lewis, RJ Bruggemann, Bart Rijnders, AH Groll, TJ Walsh

Research output: Contribution to journal › Article › Academic › peer-review

47 Citations (Scopus)

30 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	S244-S259
Journal	Clinical Infectious Diseases
Volume	68
DOIs	https://doi.org/10.1093/cid/ciz064
Publication status	Published - 2019

Research programs

@article{d8bb0b3c98a24ca1a770418feef9fd34,

title = "Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B",

author = "J Adler-Moore and RE Lewis and RJ Bruggemann and Bart Rijnders and AH Groll and TJ Walsh",

year = "2019",

doi = "10.1093/cid/ciz064",

language = "Undefined/Unknown",

volume = "68",

pages = "S244--S259",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B

AU - Adler-Moore, J

AU - Lewis, RE

AU - Bruggemann, RJ

AU - Rijnders, Bart

AU - Groll, AH

AU - Walsh, TJ

PY - 2019

Y1 - 2019

U2 - 10.1093/cid/ciz064

DO - 10.1093/cid/ciz064

M3 - Article

SN - 1058-4838

VL - 68

SP - S244-S259

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

ER -